More than three decades ago, Congress created the 340B program to help safety-net hospitals and clinics expand resources and care for underserved communities. By requiring pharmaceutical companies to ...
The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...
On July 31, the US Department of Health and Human Services’ (HHS) Health Resources and Services Administration (HRSA) announced the availability of a new pilot program altering how pharmaceutical ...
AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount program with a lawsuit that challenges the definition of what it means to be a ...
Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...
The 340B program allows certain nonprofit hospitals to buy prescription drugs at a significant discount. Larger urban hospitals generate most of the 340B revenue, while smaller rural clinics struggle ...
Federal complaints by University of Michigan, University of Kansas Hospital Authority, and Mount Sinai entities seek recovery of approximately $250 million in alleged 340B savings diversion from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results